FIELD: chemistry.
SUBSTANCE: invention relates to novel prodrugs of biologically active 2,4-pyrimidine diamine compounds with structural formula given below, hydrate, solvate and pharmaceutically acceptable salts thereof. The compounds have properties for inhibiting cascade transmission of a signal from an Fc-receptor, such as FcαRI, FcγRI, FcγRIII and FcεRI, degranulation or Syk kinase activity. Structural formula: 
EFFECT: compounds can be used to treat or prevent rheumatoid arthritis and autoimmune diseases.
25 cl, 21 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES BY MEANS OF 2,4-PYRIMIDINDIAMIN COMPOUNDS | 2003 |
|
RU2376992C2 |
| USE OF 2,4-DIAMINOPYRIMIDINES FOR TREATING ATHEROSCLEROSIS | 2009 |
|
RU2490015C2 |
| 2,4-PYRIMIDINDIAMINE COMPOUNDS HAVING EFFECT IN CASE OF AUTOIMMUNE DISORDERS | 2004 |
|
RU2356901C2 |
| COMPOSITIONS AND METHODS FOR JAK PATH INHIBITION | 2011 |
|
RU2672100C2 |
| STEREOISOMERICALLY ENRICHED 3-AMINOCARBONYL BICYCLOHEPETENE PYRIMIDINE DIAMINES AND USE THEREOF | 2005 |
|
RU2416604C2 |
| METHODS FOR TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH USE OF 2,4-PYRIMIDINEDIAMINE | 2013 |
|
RU2659777C2 |
| PRODRUG OF ADENOSINE A RECEPTOR ANTAGONISTS | 2006 |
|
RU2415858C2 |
| ENPP1 INHIBITORS AND METHODS OF MODULATING THE IMMUNE RESPONSE | 2018 |
|
RU2800798C2 |
| NOVEL CHEMICAL COMPOUNDS - 2,4-DIAMINO-1,3,5-TRIAZINE DERIVATIVES FOR PREVENTING AND TREATING HUMAN AND ANIMAL DISEASES | 2012 |
|
RU2509770C2 |
| QUINAZOLINE DERIVATIVES | 2004 |
|
RU2356896C2 |
